Belharra Therapeutics
San Diego, United States· Est.
Belharra Therapeutics employs chemoproteomics to discover small molecule drugs for historically undruggable targets in various therapeutic areas.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $50M
About
Belharra Therapeutics employs chemoproteomics to discover small molecule drugs for historically undruggable targets in various therapeutic areas.
OncologyImmunologyProteomics
Funding History
1Total raised:$50M
Series A$50M